Farm groups in both Canada and the United States are sounding warning notes over the possibility of higher prices and less competition from the pending merger of Potash Corporation of Saskatchewan and Calgary-based Agrium Inc.
The $36-billion US deal will create a massive player in the fertilizer industry. National Bank Financial says the merged firm, if approved, would control almost two-thirds of potash capacity in North America, 30 per cent of phosphate production capability and 29 per cent of nitrogen capacity.
The deal would also leave US firm Mosaic as the only other major North American potash producer.
Saskatchewan farmer Terry Boehm, chair of the National Farmers Union’s seed and trade committee, said it is unclear what the merger deal would mean for farmers, but past agricultural industry consolidation has him wary.
“Our experience with mergers, whether it be in herbicide manufacturers, seed companies, etc., has always led to higher costs to the farmer as we have very little power to negotiate as individual farmers, or even as small collectives, …with these behemoths that are being formed,” Boehm told Peter Armstrong, host of CBC News Network’s On The Money.
Full Content: CBC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas